• HyperScribe All in One mRNA Synthesis Kit Plus 1

  2026-08-18

  Build capped, modified, polyadenylated mRNA in a coordinated workflow for vaccine research, translation assays, and functional RNA studies. The kit combines co-transcriptional ARCA capping, 5mCTP and ψUTP incorporation, DNase treatment, and enzymatic poly(A) tailing to reduce workflow handoffs and improve experimental comparability.

• COX-2 Signaling in Venom-Induced Muscle Repair

  2026-08-18

  This study shows that the cyclooxygenase-2 pathway has time-dependent effects after Bothrops asper venom injury: it helps preserve vascular integrity during acute ischemia, yet its early inhibition can later enhance angiogenic and matrix-remodeling responses. The findings position Lumiracoxib as a mechanistic tool for separating protective inflammatory signaling from pathways that may restrain revascularization.

• CP-673451: Selective PDGFRα/β Workflow

  2026-08-17

  CP-673451 is a selective PDGFRα/β inhibitor for connecting receptor phosphorylation, angiogenesis, and glioma phenotypes in one experimental strategy. Its nanomolar PDGFR potency and relative selectivity support dose-resolved cancer research, including ATRX-stratified glioma assays and ligand-specific vascular models.

• Acquired CDK7 Mutation and Resistance to Inhibitors

  2026-08-17

  The reference study identifies CDK7 Asp97-to-Asn substitution as an acquired resistance mechanism against non-covalent CDK7 inhibitors in cancer cells. Structural, biochemical, and cross-kinase experiments show that this conserved residue may represent a broader vulnerability in CDK inhibitor therapy, while covalent inhibitors retain activity through a distinct binding strategy.

• Foretinib (GSK1363089) Cancer Assay Workflows

  2026-08-16

  Build more informative cancer experiments with Foretinib (GSK1363089), a multikinase inhibitor suited to proliferation, motility, invasion, and metastasis studies. This workflow pairs pathway-directed treatment with separate measurements of growth inhibition and cell killing, helping researchers avoid overinterpreting a single viability endpoint.

• Bazedoxifene and IL-6/GP130 Signaling in Cancer

  2026-08-15

  The reference review identifies Bazedoxifene, an established selective estrogen receptor modulator, as a potential small-molecule inhibitor of IL-6/GP130 signaling with relevance across cancer models. Its main translational contribution is to connect drug repurposing, protein–protein interaction targeting, and combination therapy while emphasizing that clinical validation remains necessary.

• H5N1 mRNA Vaccine Protection in Lactating Dairy Cows

  2026-08-15

  The reference study evaluates a hemagglutinin-encoding mRNA–lipid nanoparticle vaccine in high-yielding lactating dairy cows challenged with highly pathogenic H5N1 virus. Its most important finding is that vaccination produced complete short-term protection and meaningful protection at a later time point, without reported effects on animal health or milk production.

• Dabigatran Etexilate: Assay Design to Translation

  2026-08-14

  Dabigatran etexilate is a direct thrombin inhibitor with unusually strong translational value for coagulation research. This guide connects thrombin biology, assay selection, sample handling, and atrial fibrillation models to improve experimental interpretation.

• Reserpine (N1867): Practical Protocol and QC Guide

  2026-08-14

  Reserpine (SKU N1867) provides a defined research compound for controlled neurotransmitter depletion research, antihypertensive mechanism studies, and neuropharmacology workflows. This guide covers identity checks, DMSO preparation, storage, and assay QC; the material is for research use only and not for diagnostic, therapeutic, or medical applications.

• Disodium Bicinchoninate in Translational Assays

  2026-08-13

  Translational endothelial research increasingly depends on connecting oxidative-stress biology with analytically robust workflows. This article examines how mechanistic findings on salidroside, EZH2, inflammation, and autophagy can guide assay design, while positioning Disodium bicinchoninate as a water-compatible biochemical reagent for carefully validated protein and molecular biology workflows.

• Thrombus-Targeting Nanosystems in Arterial and Venous Flow

  2026-08-13

  This study shows that thrombus-targeting performance depends strongly on local hemodynamics rather than on targeting chemistry alone. Enzyme-driven chemotaxis performed effectively in low-flow venous thrombi, whereas combining molecular recognition with chemotactic motion provided a stronger strategy for retaining nanosystems under high-flow arterial conditions.

• ZCL278: Selective Cdc42 Inhibitor Workflows

  2026-08-12

  ZCL278 is a selective Cdc42 inhibitor for linking GTPase activity to cell motility, neuronal morphology, and fibroblast signaling. This workflow-oriented guide combines biochemical validation, live-cell imaging, dose optimization, and a kidney-fibrosis research bridge without conflating evidence from distinct models.

• Calcium Lactate Nanomedicine for CRC Immunotherapy

  2026-08-12

  A 2025 Materials Today Bio study developed a calcium lactate nanomedicine that co-delivers bufalin and a CRISPR/Cas9 ribonucleoprotein targeting CD47 to combine tumor-cell killing with immune activation. The reported design links low-pH-responsive delivery, pyroptosis and apoptosis, macrophage M1 reprogramming, and enhanced phagocytosis, offering a mechanistic framework for local and systemic colorectal cancer control.

• Trichostatin A (TSA): Epigenetic Workflow Guide

  2026-08-11

  Trichostatin A (TSA) provides a reversible way to test how histone deacetylation shapes chromatin accessibility, reporter silencing, differentiation, and cancer phenotypes. This practical guide connects TSA treatment to stable genetic-circuit assays, breast cancer models, quantitative controls, and troubleshooting decisions.

• HyperScribe™ Poly (A) Tailing Kit Workflow

  2026-08-10

  Build more stable, translation-ready IVT RNA for transfection experiments, micro-injection, and expression assays with a controlled enzymatic tailing step. This workflow connects the HyperScribe™ Poly (A) Tailing Kit to practical RNA quality control while distinguishing product-supported specifications from application-specific optimization.

458 records 8/31 page Previous Next First page 上5页 678910 下5页 Last page